title: [Vitiligo and morphea: autoimmune cutaneous side effects of interferon treatment].
authors: S
authors: S
authors: Martínez-García
authors: M D
authors: MD
authors: Fernández-Ballesteros
authors: J M
authors: JM
authors: Segura-Palacios
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000209:etiology / Q000473:pathology; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D011379:Prognosis; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012594:Scleroderma, Localized / Q000139:chemically induced* / Q000209:etiology / Q000473:pathology; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D014820:Vitiligo / Q000139:chemically induced* / Q000209:etiology / Q000473:pathology; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins